Get the Stockscreener App
1.90
21.79%
0.34
Equillium Inc stock is traded at $1.90, with a volume of 13.89M.
It is up +21.79% in the last 24 hours and up +385.93% over the past month.
Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its product candidates either independently or through partnerships, or otherwise monetize its pipeline through strategic transactions. Itolizumab (EQ001), a clinical-stage product candidate, is an anti-CD6 immune-modifying monoclonal antibody, or mAb, that selectively targets the CD6-ALCAM signaling pathway to downregulate pathogenic T effector cells while preserving T regulatory cells critical for maintaining a balanced immune response. The company's other clinical-stage and pre-clinical-stage candidates include EQ101 and EQ302.
See More
Previous Close:
$1.56
Open:
$1.52
24h Volume:
13.89M
Relative Volume:
1.91
Market Cap:
$67.87M
Revenue:
$45.91M
Net Income/Loss:
$-4.62M
P/E Ratio:
-13.55
EPS:
-0.1402
Net Cash Flow:
$-21.51M
1W Performance:
+66.67%
1M Performance:
+385.93%
6M Performance:
+115.91%
1Y Performance:
+102.13%
1-Day Range:
$1.51
$2.26
1-Week Range:
$1.07
$2.26
52-Week Range:
$0.27
$2.26
Equillium Inc Stock (EQ) Company Profile
Name
Equillium Inc
Sector
Industry
Phone
(858) 412-5302
Address
2223 AVENIDA DE LA PLAYA, LA JOLLA, CA
Compare EQ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EQ
Equillium Inc
|
1.90 | 47.86M | 45.91M | -4.62M | -21.51M | -0.1402 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Equillium Inc Stock (EQ) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-28-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Oct-29-21 | Resumed | Stifel | Buy |
| Sep-15-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-14-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-10-20 | Resumed | Stifel | Buy |
| Feb-22-19 | Initiated | SVB Leerink | Outperform |
View All
Equillium Inc Stock (EQ) Latest News
Equillium Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Equillium (EQ) up more than 200% since Jul 24 - AInvest
Equillium Shares Drop 12.4% After Unveiling Cryptocurrency Treasury Strategy - MSN
How to integrate Equillium Inc. into portfolio analysis toolsPrice Action & Stepwise Entry and Exit Trade Signals - Newser
Can Equillium Inc. outperform in the next rallyQuarterly Earnings Summary & Daily Profit Focused Stock Screening - thegnnews.com
Will Equillium Inc. stock go up soonEarnings Risk Report & Precise Trade Entry Recommendations - Newser
Unusual Intraday Move in Equillium (EQ.O) – What’s Behind the 16% Swing? - AInvest
Custom watchlist performance reports with Equillium Inc.Layoff News & Free Weekly Chart Analysis and Trade Guides - Newser
Will breakout in Equillium Inc. lead to full recoveryJuly 2025 Decliners & Daily Entry Point Alerts - Newser
Ranking Equillium Inc. among high performing stocks via toolsTrade Signal Summary & Daily Oversold Stock Bounce Ideas - Newser
Should you hold or exit Equillium Inc. nowQuarterly Trade Review & Stock Market Timing Techniques - Newser
Combining price and volume data for Equillium Inc.Quarterly Profit Report & AI Enhanced Market Trend Forecasts - Newser
Will Equillium Inc. benefit from green energy policiesWeekly Market Summary & Real-Time Volume Analysis Alerts - thegnnews.com
What machine learning models say about Equillium Inc.Recession Risk & AI Forecast Swing Trade Picks - Newser
Tools to monitor Equillium Inc. recovery probabilityJuly 2025 WrapUp & AI Enhanced Trading Alerts - Newser
Equillium Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView
Equillium 2024 Q4 Earnings Wider Losses Despite Record High Net Income - AInvest
Equillium (EQ) Surges 22.44% Intraday: What's Fueling This Biotech Breakout? - AInvest
Equillium (EQ) Surges 21.9% Intraday: What's Fueling This Biotech Rally? - AInvest
Unraveling the Sudden 20% Surge in Equillium (EQ.O) Despite Lack of Fundamental Catalyst - AInvest
Equillium 2024 Q4 Earnings Widening Losses Despite Record Net Loss - AInvest
Equillium's Financial Strategy and Clinical Trial Uncertainties: A Hold Rating - AInvest
Will Equillium Inc. Sustain Its Chart BreakoutMarket Risk Summary & Weekly Consistent Profit Watchlists - newsimpact.co.kr
Mintz Advises on Equillium, Inc.'s up to $50 Million PIPE - Mintz
Caroline Bertlin's Stock Transactions at eQ Plc - AInvest
Options Data Show Bullish Bias in Equillium Inc.Rate Hike & Low Risk High Win Rate Stock Picks - newsimpact.co.kr
Why Equillium Inc. is moving today2025 Growth vs Value & Fast Exit Strategy with Risk Control - Newser
Can you recover from losses in Equillium Inc.Market Performance Report & AI Enhanced Market Trend Forecasts - Newser
Janus International Group, Inc. shares rise 2.52% intraday after Equillium, Inc. secures $50 million financing package. - AInvest
Penny Stock Watchlist: Equillium, Bluejay Diagnostics, and Entero Therapeutics - AInvest
3 Penny Stocks to Watch Now, 8/12/25 - TipRanks
Equillium Stock Soars 23.02% on $50M Financing for EQ504 - AInvest
Financing at Equillium to advance EQ-504 into clinic - BioWorld MedTech
Equillium shares rise 10.61% premarket after announcing up to $50 million financing to advance EQ504. - AInvest
Equillium Stock Soars 11.74% on $50M Financing for EQ504 - AInvest
Trending tickers: latest investor updates on Intel, Tilray, monday.com, Equillium and AMC - uk.finance.yahoo.com
Wall Street Eyes: EQ, PRSO, WLGS, ENTO, GIBO Stocks Lead Sub-$1 Surge - MarketScreener
Equillium shares rise 6.09% premarket after announcing up to $50 million financing to advance EQ504. - AInvest
Equillium Stock Soars 140% on $50M Private Placement, Boosting Cash Runway Through 2027 - AInvest
Equillium Stock Soars 78.88% Amid $50 Million Financing Deal - AInvest
Measuring Equillium Inc.’s beta against major indicesAlgorithmic Prediction of Market Breakouts - Newser
Equillium EQ Q2 2025 Earnings Preview Upside Potential on Itolizumab Development Milestones - AInvest
Equillium Surges 78.88% on $230M Funding Haul, Climbs to 441st in Trading Volume Rankings - AInvest
Why Is Equillium Stock Soaring Monday?Equillium (NASDAQ:EQ) - Benzinga
Equillium: Up To $50 Million Financing Raised To Advance EQ504 - Pulse 2.0
Equillium shares jump 77.78% intraday after announcing up to $50 million financing. - AInvest
Equillium Attracts $50 Million To Advance New Drug Trials - Finimize
Gold Down Over 2%; Monday.com Shares Tumble After Q2 Results - Benzinga
Unpacking the 95% Surge in Equillium (EQ.O): What's Behind the Move? - AInvest
Equillium's 91.96% Surge: What's Fueling the Biotech Breakout? - AInvest
Equillium Stock Skyrockets on Massive Financing Boost – What This Means for Traders - RagingBull
Equillium Inc Stock (EQ) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):